Biography

Dr. Sathvik B. Sridhar is a clinical pharmacy academic and administrator with over 25 years of experience in pharmacy education, research, accreditation, and academic leadership across India, Malaysia, Australia, and the UAE. He has served in senior roles, including Associate Dean, Chairperson of Clinical Pharmacy and Pharmacology, In-Charge Head of Documentation, and MS Clinical Pharmacy Program Coordinator. His work has focused on curriculum development, quality assurance, faculty and student mentoring, interprofessional education, and strengthening the link between academic training and clinical practice. He has authored over 200 peer-reviewed publications, contributed more than 20 book chapters, published 9 books, and supervised more than 35 MSc theses and over 50 undergraduate research projects

Education

• Ph.D. in Pharmacy Practice with specialization in Renal Clinical Pharmacy, JSS College of Pharmacy / Rajiv Gandhi University of Health Sciences, India, 2008.
• M. Pharm in Pharmacy Practice / Clinical Pharmacy, JSS College of Pharmacy / Rajiv Gandhi University of Health Sciences, India, 1999.
• B. Pharm, Bangalore University, India, 1996.
• D.Pharm, Drug Control Board, Bangalore, India, 1992.
• Renal Clinical Pharmacy at the Royal Adelaide Hospital, Australia.
• Professional Diploma in Clinical Research and Pharmacovigilance training with the Uppsala Monitoring Centre.

Research Interests

• Clinical pharmacy (renal and psychiatry clinical pharmacy)
• Pharmacovigilance
• Medication safety
• Pharmacoepidemiology
• Artificial Intelligence in Healthcare

Research Publications

• Shareef J, Sridhar SB, Hamouda SA, Ali A, Thomas AC. Prescribing practices, polypharmacy, and drug interaction risks in anticoagulant therapy: insights from a secondary care hospital. J Clin Med. 2026;15(2):800.
• Al Hinai MNH, Haridas S, Shareef J, Sridhar SB, Thomas S. Community pharmacists’ perception, attitude, and practice towards herbovigilance: a cross-sectional study in Oman. J Adv Pharm Educ Res. 2026;16(1):23-33.
• Alam A, Dubey P, Joshi R, Sridhar SB, Sharma S. Drug interaction dilemmas: a database-based comparative evaluation of dual antihypertensive therapy. In Silico Res Biomed. 2026:100216.
• Kumar S, Sridhar SB, Shareef J, Wadhwa T, Meenakshi DU, Malviya R. Gallium-infused nanomaterials for cancer theranostics and biosensing: advancement and translation outlooks. J Trace Elem Miner. 2026:100281.
• Kumar S, Malviya R, Sridhar SB, Wadhwa T, Shareef J. Artificial intelligence and machine learning-driven nanorobotics for targeted brain delivery: redefining blood-brain barrier navigation. J Neurosci Methods. 2026:110695.
• Kumar N, Das J, Vanangamudi M, Mojgani N, Islam A, Sridhar SB, et al. Modulating drug response through the gut microbiome: pathways to precision therapy. Arch Microbiol. 2026;208(4):163.
• Prakash A, Malviya R, Sridhar SB, Wadhwa T, Shareef J. Exploration of inhalable nanoparticles for lung cancer therapy: advances, challenges, and future perspectives. BioNanoScience. 2026;16(2).
• Srivastava S, Jayaswal N, Gupta P, Sridhar SB, Jaiswal P, Tariq M, et al. The yellow fever vaccine journey: milestones and future directions. Vaccines (Basel). 2026;14(1):65.
• Prakash A, Malviya R, Sridhar SB, Othman RQA, Agarwal A, Wadhwa T, Shareef J. Organoid-based systems for biomedical innovation: advances in disease modeling, drug screening, and precision medicine. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jan 7. doi:10.1007/s00210-025-04848-8.
• Singh V, Hussain MS, Das J, Chellappan DK, Chaudhary P, Sridhar SB, et al. Targeting the gut microbiota with pro- and postbiotics: emerging strategies against alopecia. Probiotics Antimicrob Proteins. 2026:1-27.
• Kumar D, Malviya R, Sridhar SB. Minimally invasive laser therapy for small and large breast tumours: clinical applications and limitations. Rev Senol Patol Mamar. 2026;39(1):100724.
• Kumar D, Malviya R, Sridhar SB. Nanorobots for the treatment of breast cancer: exploration and advancement. Rev Senol Patol Mamar. 2026;39(1):100719.
• Shareef J, Sridhar SB, Saeed ZM, Alsereidi AMR. Balancing pain relief and safety: gastrointestinal and cardiovascular risk assessment in nonsteroidal anti-inflammatory drug users and the role of gastroprotective co-therapy. Pharmaceuticals (Basel). 2025 Dec 29;19(1):67.
• Shareef J, Sridhar SB, Al Naqbi SH, Bakshi AI. Beyond pain relief: a cross-sectional study on NSAID prescribing, polypharmacy, and drug interaction risks in community pharmacies. Healthcare (Basel). 2025;13(24):3264.
• Saeed ZM, Sridhar SB, Shareef J, Alsereidi AMR. From prescription patterns to drug safety: a closer look at non-steroidal anti-inflammatory drugs and analgesics in outpatient pharmacy. Front Pharmacol. 2025;16:1558830.
• Shareef J, Sridhar SB, Saeed ZM, Alsereidi AMR. Evaluation of potential drug-drug interactions, polypharmacy, and prescribing patterns of NSAIDs among older adults in a secondary care setting. Clin Interv Aging. 2025;20:1875-1894.
• Thorakkattil SA, Sridhar SB, Abdulsalim S, Karattuthodi MS, Chandra P, Unnikrishnan MK. Clinical decision support systems in Indian healthcare settings: benefits, barriers, and future implications. Healthcare (Basel). 2025;13(17):2220.
• Ramatillah DL, Halda S, Ramadhan F, Tiastiti BR, Khan KU, Sridhar SB, Darsono M, Prima SR, Aldekhail NM. Sociodemographic factors and medication use among pulmonary hypertension patients at teaching hospital Jakarta. J Pharmacol Pharmacother. 2025. doi:10.1177/0976500X251400514.
• Alam A, Saran A, Joshi R, Sridhar SB, Sharma S, Paliwal S. From algorithms to evidence: assessing artificial intelligence chatbots and drug databases for detecting cardio-diabetic drug interactions. Int J Appl Pharm. 2025;17(5):253-262.
• Seth S, Lukose L, Tesfaye WH, Sridhar SB, Thunga G, Castelino RL. Impact of Home Medicines Review on medication regimen complexity. J Pharm Pract Res. 2025;55(2):102-109.
• Srivastava S, Anbiaee R, Houshyari M, Laxmi, Sridhar SB, Ashique S, Hussain S, Kumar S, Taj T, Akbarnejad Z, Taghizadeh-Hesary F. Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance. Cancer Cell Int. 2025;25:89.
• Parashar B, Sridhar SB, Kalpana, Malviya R, Prajapati BG, Uniyal P. Advances in machine learning models for healthcare applications: a precise and patient-centric approach. Curr Pharm Des. 2025.
• Srivastava S, Sharma D, Sridhar SB, Kumar S, Sahu R, Ashique S, Mohanty A, Sah S, Mehta V, Mehta R, Apostolopoulos V. HKU5-CoV-2: a silent threat looming in bats. Travel Med Infect Dis. 2025;65:102838.
• Porwal S, Malviya R, Sridhar SB, Shareef J, Wadhwa T. Global impact of hMPV virus: transmission, pathogenesis, diagnosis, and treatment. Diagn Microbiol Infect Dis. 2025:116809.
• Porwal S, Malviya R, Sridhar SB, Shareef J, Wadhwa T. Mysterious Oropouche virus: transmission, symptoms, and control. Infect Med. 2025:100177.
• Shareef J, Sridhar SB, Ahmad Ismail AN, et al. Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital. F1000Res. 2025;13:164.
• Srivastava S, Sharma D, Sridhar SB, et al. Comparative analysis of Mpox clades: epidemiology, transmission dynamics, and detection strategies. BMC Infect Dis. 2025;25:1290. doi:10.1186/s12879-025-11784-8.
• Srivastava S, Sharma D, Sridhar SB, et al. The emergence of Oropouche fever: a potential new threat? New Microbes New Infect. 2025:101596.
• Khan HA, Haq R, Awan AA, Mehmood K, Ghazanfar S, Debnath B, Ashique S, Mondal M, Sridhar SB, Ansari MY, Hussain MS. Evaluation of suitability, efficacy, and safety of zinc hydroxide adjuvant system adsorbed on tetanus toxoid vaccine. Mol Biotechnol. 2025 Nov 6:1-14.
• Wali AF, Pillai JR, Talath S, Shivappa P, Sridhar SB, El-Tanani M, Rangraze IR, Mohamed OI, Al Ani NN. Phytochemicals in breast cancer prevention and treatment: a comprehensive review. Curr Issues Mol Biol. 2025;47(1):30
• Verma S, Malviya R, Sridhar SB, Sundram S, Shareef J. Neurostimulation for the management of epilepsy: advances in targeted therapy. Curr Drug Targets. 2025;26(10):709-721.
• Goud M, Abdelghani MMSM, Bairy LK, John AA, Prabu JLRP, Sridhar A, Hakim THM, Sridhar SB, Shareef J. Evaluating the association between blood types and COVID-19 infection: a retrospective investigation carried out in the Northern Emirates of the United Arab Emirates. J Appl Pharm Sci. 2025;15(5):149-155.
• Porwal S, Malviya R, Sridhar SB, Kaur M. Emerging Threats and Challenges of Monkeypox Virus: Exploration and Sensitivity. Curr Drug Targets. 2025;26(5):295-297.
• Porwal S, Malviya R, Sundram S, Sridhar SB, Shareef J. Diabetic Wound Healing: Factors, Mechanisms, and Treatment Strategies Using Herbal Components. Curr Drug Targets. 2025;26(6):367-381.
• Ashique S, Srivastava S, Sridhar SB, et al. Outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Indonesia in 2023-2024. Egypt J Intern Med. 2025;37:38.
• Kumar D, Malviya R, Srivastava S, Sridhar SB, Talath S, Shareef J, Prajapati BG. Personalized immunization against Mpox clades I and Ib: strategies to combat the emerging epidemic. Infect Med. 2025;4(1):100166.